Clinical manifestations, diagnosis, and antimicrobial resistance of group A streptococci infections

키워드

참고문헌 (41)

1. Watkins DA, "Global, regional, and national burden of rheumatic heart disease, 1990–2015", N Engl J Med, 377, pp.713~722 (2017)
2. Lv M, "Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990–2019", Eur J Prev Cardiol, 29, pp.1425~1434 (2022)
3. Luo R, "Diagnosis and management of group A streptococcal pharyngitis in the United States, 2011–2015", BMC Infect Dis, 19, pp.1~9 (2019)
4. 김지애, "건강보험청구자료를 이용한 외래 급성 호흡기계 질환 방문과 항생제 처방률 변화 분석", 한국임상약학회지, 27(3), pp.186~194 (2017), 한국임상약학회[DOI]
5. Kalra MG, "Common questions about streptococcal pharyngitis", Am Fam Physician, 94, pp.24~31 (2016)
6. Kim S, "Predominance of emm4 and antibiotic resistance of Streptococcus pyogenes in acute pharyngitis in a southern region of Korea", Int J Med Microbiol, 68, pp.1053~1058 (2019)
7. Johnson DR, "Characterization of group A streptococci(Streptococcus pyogenes) : correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor", J Med Microbiol, 55, pp.157~164 (2006)
8. Kim S, "Epidemiological usefulness of anti-opacity factor antibody screening in schoolchildren", J Clin Microbiol, 39, pp.1316~1318 (2001)
9. Brouwer S, "Pathogenesis, epidemiology and control of Group A Streptococcus infection", Nat Rev Microbiol, 21, pp.431~447 (2023)
10. Pastural É, "Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I study", Vaccine, 38, pp.1384~1392 (2020)
11. Dale JB, "New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci", Vaccine, 29, pp.8175~8178 (2011)
12. Hosier DM, "Resurgence of acute rheumatic fever", Am J Dis Child, 141, pp.730~733 (1987)
13. Rush CM, "Animal models to investigate the pathogenesis of rheumatic heart disease", Front Pediatr, 2, pp.116~ (2014)
14. Bruun T, "Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway", Clin Microbiol Infect, 19, pp.E545~E550 (2013)
15. Ikebe T, "Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012", Epidemiol Infect, 143, pp.864~872 (2015)
16. Schmitz M, "Streptococcal toxic shock syndrome in the intensive care unit", Ann Intensive Care, 8, pp.1~10 (2018)
17. Cordery R, "Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever : a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK", Lancet Microbe, 3, pp.e366~e375 (2022)
18. Kim SJ, "Distribution and upper limit of normal antistreptolysin O concentrations of school", Korean J Infect Dis (1997)
19. Bennett J, "Comparison of group A streptococcal titres in healthy children and those with pharyngitis and skin infections", J Infect, 84, pp.24~30 (2022)
20. Lacey JA, "Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia : a retrospective genomic analysis", Lancet Microbe, 4, pp.E524~33 (2023)
21. Keeley AJ, "Streptococcus pyogenes colonization in children aged 24–59 months in the Gambia : impact of live attenuated influenza vaccine and associated serological responses", J Infect Dis, 228, pp.957~965 (2023)
22. Kim SJ, "Optimal site of throat swab for the isolation of beta-hemolytic streptococci", J Korean Med Sci, 8, pp.453~457 (1993)
23. Pires R, "Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes", FEMS Microbiol Lett, 296, pp.235~240 (2009)
24. Berry GJ, "Comparison of the Alere i Strep A test and the BD Veritor system in the detection of group A Streptococcus and the hypothetical impact of results on antibiotic utilization", J Clin Microbiol, 56, pp.e01310~e01317 (2018)
25. Cohen JF, "Rapid antigen detection test for group A streptococcus in children with pharyngitis", Cochrane Database Syst Rev, 7, pp.CD010502~ (2016)
26. Close RM, "Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections : a validation study", Diagn Microbiol Infect Dis, 103, pp.115729~ (2022)
27. May L, "The impact of point-of-care polymerase chain reaction testing on prescribing practices in primary care for management of Strep A : a retrospective before–after study", Open Forum Infect Dis, 9, pp.ofac147~ (2022)
28. Ebell MH, "Does this patient have strep throat?", JAMA, 284, pp.2912~2918 (2000)
29. Jo Seon A, "Diagnostic Impact of Clinical Manifestations of Group A Streptococcal Pharyngitis", Infection and Chemotherapy, 53(3), pp.553~556 (2021), 대한감염학회[DOI]
30. Kim SJ, "Distribution and upper limit of normal antistreptolysin O concentrations according to age", Korean J Infect Dis (1998)
31. McMillan DJ, "Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study", Clin Microbiol Infect, 19, pp.E222~9 (2013)
32. Rafei R, "A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: a systematic review", Infect Genet Evol, 99, pp.105258~ (2022)
33. Choi JH, "Distribution of emm types among group A Streptococcus isolates from children in Korea", Diagn Microbiol Infect Dis, 82, pp.26~31 (2015)
34. Kim HN, "Performance evaluation of three rapid antigen tests for the diagnosis of group A Streptococci", BMJ Open, 9, pp.e025438~ (2019)
35. Cho YN, "Distribution of emm genotypes in group A streptococcus isolates of Korean children from 2012 to 2019", J Microbiol Immunol Infect, 55, pp.671~677 (2022)
36. Li Y, "Continued increase of erythromycin nonsusceptibility and clindamycin nonsusceptibility among invasive group A streptococci driven by genomic clusters, United States, 2018–2019", Clin Infect Dis, 76, pp.e1266~e1269 (2023)
37. Wajima T, "Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010–2012", Int J Antimicrob Agents, 42, pp.447~449 (2013)
38. Lu B, "High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016", Front Microbiol, 8, pp.1052~ (2017)
39. Li H, "Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China", BMC Infect Dis, 20, pp.1~9 (2020)
40. Shulman ST, "Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis : 2012 update by the Infectious Diseases Society of America", Clin Infect Dis, 55, pp.e86~e102 (2012)
41. McGuire E, "Time to negative throat culture following initiation of antibiotics for pharyngeal group A Streptococcus : a systematic review and meta-analysis up to October 2021 to inform public health control measures", Euro Surveill, 28, pp.2200573~ (2023)

관련 논문AI추천